Executive Search

Occam partners with organizations in the life sciences, technology, and investment sectors to recruit C-Suite executives across both the commercial and R&D functions.

Recent Placements

Occam Places Hans Bitter as SVP and Head, Data Science of MOMA Therapeutics

Recursion Pharmaceuticals

Occam Places Ramona Doyle as CMO at Recursion

Occam Places Emily Conley as CEO of Federation Bio

Occam Places Matthew Gall as CFO of iTeos Therapeutics

Variant Bio

Chief Executive Officer (CEO) placed at Variant Bio, a Lux Capital-backed newco examining outlier genetic populations to inform novel drug development

Beam Therapeutics

Wall Street luminary placed as Chief Financial Officer (CFO) of Beam Therapeutics [BEAM], an F-Prime/Arch-backed gene therapy platform company

Oncorus

Placed an accomplished R&D oncology general manager from Moderna as Chief Executive Officer (CEO) of Oncorus, an MPM-backed oncolytic virus company

eGenesis Bio

Placed Chief Executive Officer (CEO) at eGenesis, an Arch-backed gene therapy company focusing on pig-to-human organ transplantation

Chiasma

Seasoned rare disease commercial leader placed at helm of Chiasma [CHMA], a biopharma company preparing to launch a transformative treatment for acromegaly

CytomX Therapeutics

Chief Financial Officer (CFO) recruited for CytomX Therapeutics [CTMX] after successfully placing multiple board members

NOCION Therapeutics

Chief Business Officer (CBO) placed at NOCION Therapeutics, a biopharma company developing novel treatments for silencing neurons

Elicio Therapeutics

Occam Places Chris Haqq as CMO and EVP R&D at Elicio Therapeutics

PACT Pharma

Chief Financial Officer (CFO) placed at PACT Pharma, a company aiming to re-program one’s own immune system to target and eradicate cancer

Case Studies

Beam Therapeutics

Biotech firm Beam Therapeutics is pioneering the use of CRISPR base editing techniques that enable the permanent rewriting of single letters in the human genome.

View Case

Chiasma

Chiasma is a public, clinical-stage biopharmaceutical company focused on improving the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases.

View Case

Elicio Therapeutics

Elicio Therapeutics is committed to transforming the lives of patients by re-engineering the body’s immune response to defeat cancer.

View Case

Semma Therapeutics

Semma Therapeutics is pioneering the new treatment paradigm of using cells as medicine.

View Case

Zero Mass Water

Zero Mass Water has developed a proprietary solar-powered system that draws on vapor in the atmosphere to produce drinking water.

View Case